US Patent 10653791 Antibodies comprising modified heavy constant regions
Patent 10653791 was granted and assigned to Bristol-Myers Squibb on May, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10653791 Antibodies comprising modified heavy constant regions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
